Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
2.
Int J Angiol ; 32(3): 158-164, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37576529

ABSTRACT

Acute limb ischemia (ALI) is a predictor of high morbidity and mortality. Previous studies showed that ALI developed after cardiac surgery may increase mortality. This study aimed to elucidate the clinical course and identify risk factors contributing to mortality in patients with ALI after cardiovascular surgery. This is a single-center retrospective cohort study. We analyzed data from 52 patients with ALI after cardiovascular surgery between 2016 and 2020. We evaluated the risk factors for 1-year mortality using Cox proportional hazards regression analysis. Most of the patients with ALI were male and the median age was 56 years (23-72 years). Most of the patients with ALI had coronary artery diseases. The 1-year mortality rate was 55.8% ( n = 29 patients). Multivariable analysis revealed that cardiopulmonary bypass (CPB) time ≥ 100 minutes (hazard ratio [HR]: 3.067, 95% confidence interval [CI]: 1.158-8.120) and postoperative acute kidney injury (HR: 2.927, 95% CI: 1.358-6.305) were significantly increasing the risk of mortality in patients with ALI after an operation. ALI after cardiovascular surgery was associated with high 1-year mortality in our study and long CPB time and postoperative acute kidney injury contributed to the mortality.

3.
Acta Chir Belg ; 123(6): 654-658, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36250679

ABSTRACT

BACKGROUND: To evaluate the value of ultrasound (US), computed tomography (CT) and laboratory testing in diagnosing acute appendicitis and to evaluate the impact on the treatment of acute appendicitis, keeping histopathology as the gold standard. Retrospective evaluation of all patients treated surgically for appendicitis from 1 January 2016 to 31 December 2018 at Sint-Andries Hospital, Tielt, Belgium. METHODS: For each patient, we recorded: age, sex, duration of hospitalization, type of radiological investigation, fever (>37.3 °C), C-reactive protein (CRP), leukocyte particle count (LPC), Alvarado score and the type of surgery. For US and CT sensitivity, specificity and negative appendectomy rate were evaluated. RESULTS: Over a period of 3 years, 304 appendectomies were performed. The overall prevalence of appendicitis was 95.1%. Mean age was 31 years. All patients underwent radiological examination. US was performed in 35.9% (109), CT in 50.3% (153) and CT after US in 13.8% (42) of all cases. The sensitivity and specificity of CT were 99.4% and 80.0%, respectively. For US, the respective figures were 74.8 and 62.5%. CRP and LPC were significantly higher in the appendicitis group, compared to the non-appendicitis group. The negative appendectomy rate was slightly higher in the CT after US group i.e. 7.1% (3/42) compared to 4.67% (5/107) in the US group and 4.50% (7/155) in the CT group. CONCLUSIONS: The diagnostic value of US and CT are both very high. The diagnostic value of clinical features and biochemistry alone is quite low. By combining radiological examination, clinical examination and laboratory values, low negative appendectomy rates can be achieved.


Subject(s)
Appendicitis , Humans , Adult , Appendicitis/diagnostic imaging , Appendicitis/surgery , Retrospective Studies , Appendectomy/methods , Tomography, X-Ray Computed/methods , Sensitivity and Specificity , Ultrasonography/methods , Acute Disease , C-Reactive Protein
5.
Int Angiol ; 41(3): 232-239, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35179342

ABSTRACT

BACKGROUND: The aim of this observational study was to examine how general practitioners (GP) in Belgium treat patients with chronic venous disease (CVD). METHODS: This cross-sectional study was carried out in Belgium by GPs who recruited 15 consecutive patients who were consulting them and suffered from CVD. By following a standardized questionnaire, they collected information on patient characteristics, risk factors, signs and symptoms, and how they were being managed. RESULTS: Two hundred fifty-three GPs recruited 3055 patients, who were predominantly female (75.6%), with a mean age of 62.7 (SD=14.6). 20.1% of the population suffered from CVD without clinical signs (C0s). 8.7% of the population had advanced disease (C5-C6). Most common symptoms were respectively "heavy legs" (43.7%), "swollen feeling" (28%) and "pain" (24.1%). The primary care physicians decided 95.3% of patients needed therapy of some sort. The most used treatment option used in 83.3% of subjects was the use of venoactive medication. Lifestyle advice was recommended in 64.5% of patients and recommendations regarding compression stockings were given in 46.9% of patients. Referral to a specialist was warranted for 24.5% of the population. Patients with a lower C Classification were more often treated conservatively compared to those with a higher C Classification. CONCLUSIONS: Most patients were treated conservatively, which includes lifestyle changes, medication, and compression. Only one in four patients is referred to a vascular specialist and this referral is significantly positively correlated with the C Classification.


Subject(s)
General Practice , Vascular Diseases , Belgium/epidemiology , Chronic Disease , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Vascular Diseases/epidemiology
6.
Int Angiol ; 41(4): 322-331, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35166103

ABSTRACT

BACKGROUND: The treatment of chronic venous disease, has largely shifted from high ligation and stripping to endovenous thermal ablation (EVTA) techniques, because of its comparable efficacy and lack of invasiveness. This clinical trial aimed to compare the efficacy of two thermal ablation techniques, endovenous laser ablation (EVLA) 1470-nm with Tulip-TipTM fiber and radiofrequency ablation (RFA) ClosureFastTM using a non-inferiority design for occlusion rate (primary outcome). METHODS: A prospective multicenter randomized clinical trial randomized 280 patients for the treatment of great saphenous vein (GSV) reflux. Primary outcome was the GSV occlusion rate, secondary outcome factors were the possible side-effects of the treatment such as pain, ecchymosis, quality of Life (CIVIQ-20), revised Venous Clinical Severity Score (r-VCSS). One-year follow-up period. RESULTS: The total occlusion rates at one year follow-up were 96.4% and 94.5% in the EVLA and RFA groups respectively (P=0.15). Regarding secondary outcomes, such as postoperative CIVIQ-20, r-VCSS, analgesia, absenteeism, there was no significant difference between both treatment groups. CONCLUSIONS: RFA and EVLA, using a 1470 nm laser with Tulip-TipTM fiber, of the GSV results in equal occlusion rates at one year, with comparable postoperative pain and improved quality of life.


Subject(s)
Laser Therapy , Tulipa , Varicose Veins , Venous Insufficiency , Humans , Laser Therapy/adverse effects , Lasers, Semiconductor/adverse effects , Prospective Studies , Quality of Life , Saphenous Vein/diagnostic imaging , Saphenous Vein/surgery , Treatment Outcome , Varicose Veins/surgery , Venous Insufficiency/surgery
8.
Int Angiol ; 39(4): 267-275, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32083430

ABSTRACT

BACKGROUND: To date, it is unclear how treatment of patients with chronic venous disease (CVD) is influenced by national reimbursement systems. In Belgium, catheters or fibers used for endovenous thermal ablation (EVTA) are reimbursed only once in a lifetime. The potential impact of the Belgian public health insurance reimbursement policy on surgical practice in phlebology needs to be investigated. METHODS: Billing data available from the Belgian National Institute for Health and Disability Insurance (NIHDI) were used for analyzing the distribution of specific surgical procedures for treating varicose veins and their relative use from 2007 to 2017. The potential influence of age, sex, social status and geographical origin of insured patients on surgical practice in Belgium were studied. RESULTS: The annual intervention rate was 343 per 100,000 insured individuals for 2017 with a slight annual increase over the period 2007-2017 (+ 0.83% per year). Patients with limited resources, benefiting from a preferential reimbursement system, had a significantly lower intervention rate than those having the usual system (P<0.001). There was a large geographical variation in the use of care, ranging from 172 to 549 per 100.000 insured in 2017. The number of classic surgical procedures decreased (-6.17% per year) in the period 2015-2017) while EVTA, newly reimbursed in Belgium since 2012, increased during the same period (+ 3.6% per year). This evolution was more pronounced in the north (Flanders) than in the south (Wallonia) of the country. Bilateral treatment increased considerably from 2012 and stabilized at 33% of all surgical interventions in 2016 and 2017. CONCLUSIONS: Available data of the NIHDI in Belgium highlight remarkable differences in the use of care for CVD, depending on social status and geographical origin of insured patients. The introduction of EVTA techniques has been adopted more rapidly in the north of the country and has led to an increased percentage of bilateral procedures.


Subject(s)
Vascular Diseases , Belgium , Humans , Policy , Veins
10.
Int Angiol ; 38(1): 22-38, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30465420

ABSTRACT

Varicose vein surgery is among the most commonly performed surgical interventions. The standard treatment 'high ligation and stripping' has in many countries been replaced by endovenous techniques. However, there are many different techniques available. All have a different way of action and sometimes need different skills. The purpose of this review article is to give an update in those different endovenous ablation techniques. We describe the indications, technique, mechanisms of action, and results. We conclude that all different techniques can be used safely and are effective. Even on long term there seems to be no difference in outcome, even compared to high ligation and stripping.


Subject(s)
Angioplasty, Laser/methods , Catheter Ablation/methods , Varicose Veins/surgery , Angioplasty, Laser/adverse effects , Catheter Ablation/adverse effects , Humans , Saphenous Vein/surgery , Treatment Outcome , Ultrasonography, Doppler, Duplex , Varicose Veins/diagnostic imaging
11.
Angiology ; 69(9): 779-785, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29482348

ABSTRACT

This study measured the prevalence of chronic venous disease (CVD, C1-C6), chronic venous insufficiency (C3-C6) in 23 countries. The possible influence of risk factors was assessed. Patient recruitment was carried out by general practitioners. Patient characteristics, prevalence of risk factors, and C-classification were recorded. We assessed differences in prevalence and risk factors between Asia (A), Eastern Europe (EE), Latin America (LA), and Western Europe (WE). A total of 99 359 patients were included. The prevalence of CVD (51.9% A, 70.18% EE, 68.11% LA, and 61.65% WE) was significantly ( P < .001) lower in A. Risk factors such as age, obesity, smoking, having regular exercise, use of birth control pills, prolonged standing and sitting, and having a positive family history differ significantly between regions. After model-based probabilities corrected for risk factors, significant differences in the probability of having CVD were only found in the older age-group (>65 years). The lowest prevalence was noted in A. Chronic venous disease is very common and the prevalence varies between different geographical areas. After correcting for risk factors, these differences diminished.


Subject(s)
General Practice , Venous Insufficiency/epidemiology , Adult , Aged , Asia/epidemiology , Chronic Disease , Europe/epidemiology , Female , Humans , Latin America/epidemiology , Male , Middle Aged , Prevalence , Risk Factors , Surveys and Questionnaires , Venous Insufficiency/diagnosis
12.
Phlebology ; 31(5): 325-33, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26036248

ABSTRACT

AIM: The aim of this study is to measure the incidence of the symptoms in patients with chronic venous disease (CVD) and to look for the influence of age on the severity of symptoms for both genders. MATERIALS AND METHODS: A survey was carried out in Belgium and Luxembourg between May and September 2013. Patient recruitment was done by 406 general practitioners (GPs). Each GP screened 10-20 consecutive patients older than 18 years. Inquiries were made regarding the presence of symptoms and possible signs of CVD. Patients with diagnosed CVD filled out a questionnaire including a quality of life score (CIVIQ-14). These data were converted into a CIVIQ Global Index Score (GIS). Statistical analysis was performed in order to calculate the effect of age and gender on the number of symptoms and the estimated probabilities of having CVD. RESULTS: Totally 6009 patients were included in this survey. The mean age was 53.4 years. Of all, 61.3% of the patients have CVD (C1-C6). Of all, 64.7% of patients were symptomatic. Age and female gender were major risk factors for developing CVD. Most common symptoms were 'heavy legs' (70.4%), pain (54.0%), and sensation of swelling (52.7%). The number of symptoms increases with age (p < 0.001). Female patients have significantly more symptoms in comparison with male patients in all age groups. In both females and males, age is negatively correlated with GIS score (p < 0.001). The estimated probability of having CVD was significantly higher for woman compared to men and increases with age for both gender. CONCLUSION: CVD is a very common progressive disease with age as a major risk factor. Increasing age results in a higher C-classification, more symptoms, and a lower GIS score (quality of life). Female gender interacts significantly with age and results in a more advanced stage of CVD.


Subject(s)
Varicose Veins/epidemiology , Varicose Veins/pathology , Varicose Veins/physiopathology , Adult , Age Factors , Aged , Belgium/epidemiology , Chronic Disease , Female , Humans , Luxembourg/epidemiology , Male , Middle Aged , Risk Factors , Sex Factors
14.
Lasers Med Sci ; 29(2): 501-7, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24338133

ABSTRACT

Many different types of fiber tips have been developed over the last few years to be used in endovenous laser ablation (EVLA) procedures. All these new but different tips claim a certain superiority over the other tips. Evidence for a best tip is however lacking. Four of these fiber tips have been compared in this article: (1) the bare fiber, (2) the Tulip-Tip, (3) the NeverTouch™ tip, and (4) the radially emitting tip. The aim of this paper is to provide information on the technical differences between these fiber tips and differences in their underlying heat transfer mechanisms. Although all tips are effective in the primary goal of EVLA, namely to occlude the incompetent vein, they differ in side effects, they differ in side effects, practicality, and cost. Although these new tips have improved EVLA, the perfect tip is not on the market yet.


Subject(s)
Laser Therapy/instrumentation , Laser Therapy/methods , Varicose Veins/surgery , Endovascular Procedures/instrumentation , Endovascular Procedures/methods , Equipment Design , Fiber Optic Technology , Hot Temperature , Humans , Veins/anatomy & histology
15.
Lasers Med Sci ; 29(2): 441-52, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24105396

ABSTRACT

Minimally invasive treatment of varicose veins by endovenous laser ablation (EVLA) becomes more and more popular. However, despite significant research efforts performed during the last years, there is still a lack of agreement regarding EVLA mechanisms and therapeutic strategies. The aim of this article is to address some of these controversies by utilizing optical-thermal mathematical modeling. Our model combines Mordon's light absorption-based optical-thermal model with the thermal consequences of the thin carbonized blood layer on the laser fiber tip that is heated up to temperatures of around 1,000 °C due to the absorption of about 45% of the laser light. Computations were made in MATLAB. Laser wavelengths included were 810, 840, 940, 980, 1,064, 1,320, 1,470, and 1,950 nm. We addressed (a) the effect of direct light absorption by the vein wall on temperature behavior, comparing computations by using normal and zero wall absorption; (b) the prediction of the influence of wavelength on the temperature behavior; (c) the effect of the hot carbonized blood layer surrounding the fiber tip on temperature behavior, comparing wall temperatures from using a hot fiber tip and one kept at room temperature; (d) the effect of blood emptying the vein, simulated by reducing the inside vein diameter from 3 down to 0.8 mm; (e) the contribution of absorbed light energy to the increase in total energy at the inner vein wall in the time period where the highest inner wall temperature was reached; (f) the effect of laser power and pullback velocity on wall temperature of a 2-mm inner diameter vein, at a power/velocity ratio of 30 J/cm at 1,470 nm; (g) a comparison of model outcomes and clinical findings of EVLA procedures at 810 nm, 11 W, and 1.25 mm/s, and 1,470 nm, 6 W, and 1 mm/s, respectively. Interestingly, our model predicts that the dominating mechanism for heating up the vein wall is not direct absorption of the laser light by the vein wall but, rather, heat flow to the vein wall and its subsequent temperature increase from two independent heat sources. The first is the exceedingly hot carbonized layer covering the fiber tip; the second is the hot blood surrounding the fiber tip, heated up by direct absorption of the laser light. Both mechanisms are about equally effective for all laser wavelengths. Therefore, our model concurs the finding of Vuylsteke and Mordon (Ann Vasc Surg 26:424-433, 2012) of more circumferential vein wall injury in veins (nearly) devoid of blood, but it does not support their proposed explanation of direct light absorption by the vein wall. Furthermore, EVLA appears to be a more efficient therapy by the combination of higher laser power and faster pullback velocity than by the inverse combination. Our findings suggest that 1,470 nm achieves the highest EVLA efficacy compared to the shorter wavelengths at all vein diameters considered. However, 1,950 nm of EVLA is more efficacious than 1,470 nm albeit only at very small inner vein diameters (smaller than about 1 mm, i.e., veins quite devoid of blood). Our model confirms the efficacy of both clinical procedures at 810 and 1,470 nm. In conclusion, our model simulations suggest that direct light absorption by the vein wall is relatively unimportant, despite being the supposed mechanism of action of EVLA that drove the introduction of new lasers with different wavelengths. Consequently, the presumed advantage of wavelengths targeting water rather than hemoglobin is flawed. Finally, the model predicts that EVLA therapy may be optimized by using 1,470 nm of laser light, emptying of the vein before treatment, and combining a higher laser power with a greater fiber tip pullback velocity.


Subject(s)
Laser Therapy/methods , Models, Theoretical , Varicose Veins/surgery , Endovascular Procedures/methods , Hot Temperature , Humans , Optics and Photonics/methods , Saphenous Vein/diagnostic imaging , Saphenous Vein/physiopathology , Saphenous Vein/surgery , Temperature , Time Factors , Ultrasonography , Varicose Veins/diagnostic imaging , Varicose Veins/physiopathology
16.
Ann Vasc Surg ; 26(3): 424-33, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22305475

ABSTRACT

BACKGROUND: The aim of this article is to summarize and review the proposed theories on the laser action during endovenous ablation. METHODS: Laser mechanics and laser-tissue interaction are summarized from articles found in literature. Several theories, like the "steam bubble theory," the "direct contact theory," the "heat pipe," and "direct light energy absorption" are discussed. RESULTS: The laser light emitted intraluminally can be absorbed, scattered, or reflected. Reflection is negligible in the near-infrared spectrum. By combining absorption and scattering, the optical extinction of different wavelengths related to different biological tissues can be determined. The direct contact of the fiber tip and the vein wall may be a way of destroying the vein wall, but results in ulcerations and perforations of the vein wall. Avoiding this contact, and allowing direct light absorption into the vein wall, results in a more homogenous vein wall destruction. If the energy is mainly absorbed by the intraluminal blood, the laser fiber will act as a heat pipe. Histological studies show that a more circumferential vein wall destruction can be obtained when the vein is emptied of its intraluminal blood. The use of tumescent liquid reinforces spasm of the vein and protects the perivenous tissue. CONCLUSION: Several factors play an important role in the mechanism of endovenous laser ablation. Direct energy absorption by the vein wall is the most efficient mechanism. It is important to empty the vein of its intraluminal blood and to inject tumescent liquid around the vein.


Subject(s)
Endovascular Procedures , Laser Therapy , Saphenous Vein/surgery , Venous Insufficiency/surgery , Anesthesia, Local , Animals , Endovascular Procedures/adverse effects , Endovascular Procedures/instrumentation , Equipment Design , Humans , Laser Therapy/adverse effects , Laser Therapy/instrumentation , Lasers , Saphenous Vein/pathology , Treatment Outcome , Venous Insufficiency/blood , Venous Insufficiency/pathology
17.
Vasc Endovascular Surg ; 42(2): 141-9, 2008.
Article in English | MEDLINE | ID: mdl-18238860

ABSTRACT

The aim of this study was to report the results of high-energy endovenous laser treatment to measure the relationship between the fluence and the outcome in terms of recanalization. In 97 patients, 129 great saphenous veins were treated with endovenous laser treatment, using a 980-nm diode laser. Follow-up visits were done at 3 days, 1 month, and 6 months. The best results were noted 1 month postoperative, but at 6 months, control late recanalizations occurred decreasing occlusion rate to 90.6%. Patients were divided into 2 groups according to the outcome (occlusion or recanalization) at 6 months, and statistical analysis was done. The authors found 52 J/cm(2) mean fluence in the occlusion group and 43.7 J/cm(2) in the nonocclusion group. This was a statistical significant difference (P < .01). The occlusion rate on long term is fluence dependent. But recanalizations might occur even in these higher fluence treatment groups. A fluence of 52 J/cm(2) is advised.


Subject(s)
Laser Therapy/methods , Saphenous Vein/surgery , Venous Insufficiency/surgery , Adult , Aged , Female , Humans , Laser Therapy/adverse effects , Male , Middle Aged , Prospective Studies , Saphenous Vein/diagnostic imaging , Secondary Prevention , Time Factors , Treatment Outcome , Ultrasonography, Doppler, Duplex , Ultrasonography, Interventional , Venous Insufficiency/diagnostic imaging
18.
Acta Orthop Belg ; 70(4): 386-8, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15481429

ABSTRACT

Nocardia is a gram positive, aerobic branched actinomycete; it is an ubiquitous soil saprophyte. As an infecting agent it has been increasingly identified in humans, especially in immuno-suppressed hosts. Nocardia as a cause of septic arthritis is very unusual. The described genus was Nocardia asteroides in nearly all previously reported cases. We report an unusual case of spontaneous Nocardia farcinica septic arthritis of the left knee in a 68-year-old man, who was under systemic corticosteroids for chronic obstructive pulmonary disease. The diagnosis was rapidly made by Gram and acid-fast stains and later confirmed by culture. PCR was used to identify the subtype. The patient was treated successfully with sulphametaxazole-trimethoprim for six months. Our case re-emphasises, especially in the immuno-compromised patient, the importance of performing fungal and acid-fast bacilli cultures, besides the most common bacterial cultures for aerobic and anaerobic organisms, in order to identify less common organisms and to initiate early and adequate treatment.


Subject(s)
Arthritis, Infectious/diagnosis , Knee Joint , Nocardia Infections/diagnosis , Nocardia/isolation & purification , Aged , Arthritis, Infectious/complications , Arthritis, Infectious/drug therapy , DNA, Bacterial/analysis , Follow-Up Studies , Humans , Male , Nocardia/classification , Nocardia Infections/complications , Nocardia Infections/drug therapy , Polymerase Chain Reaction , Risk Assessment , Severity of Illness Index , Tomography, X-Ray Computed , Treatment Outcome , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
19.
Acta Orthop Belg ; 69(4): 382-4, 2003 Aug.
Article in English | MEDLINE | ID: mdl-14526648

ABSTRACT

Pseudoaneurysm formation is a rare complication after knee arthroscopy. Most pseudoaneurysms complicating knee arthroscopy develop on the popliteal and geniculate arteries. We report a case of a pseudoaneurysm developed on an arterial branch to the medial gastrocnemius muscle, as a complication of an arthroscopic meniscectomy in a 66-year-old patient. The patient was treated successfully by resection of the pseudoaneurysm and ligation of the injured artery.


Subject(s)
Aneurysm, False/etiology , Arthroscopy/adverse effects , Menisci, Tibial/surgery , Muscle, Skeletal/blood supply , Aged , Aneurysm, False/surgery , Female , Humans , Ligation , Tibial Meniscus Injuries , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...